We sweep the internet for research funding across disease areas and research fields — federal, foundation, state & industry sources in one filterable place.

← Back to opportunities
OpenU01NIDDKClinical trial: Not allowed

The NIDDK Disorders of Gastrointestinal Interoception Consortium (DGIC) - Clinical Research Centers (U01 Clinical Trial Not Allowed)

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · NIH Institute/Center · RFA-DK-28-213

Source: Grants.gov · View original posting ↗

Award
Up to $500K
Deadline
Mar 5, 2027
Letter of intent
—
Mechanism
U01
Duration
—
Expected awards
6
Funding cycle
One-time
Open date
Nov 3, 2026
Total funding
$4.5M total
Clinical trial
Not allowed
Established investigatorGovernmentHigher educationSmall businessNonprofitForeign entities

Research areas

Basic mechanisms & biologyBiomarkers & diagnosticsTherapeutics & drug discoveryClinical trials

Auto-classified from the title and description (keyword-based) — may be imperfect.

Description

This Notice of Funding Opportunity (NOFO) invites new applications to participate in the Diseases of Gastrointestinal Interoception Consortium (DGIC). The overall objectives of this consortium are to: 1) identify the underlying mechanisms that link altered GI interception more directly to GI dysmotility and symptoms; 2) identify disease or response biomarkers that better assess pathophysiology or treatment efficacy; and 3) leverage state-of-the-art technologies to identify novel therapeutic targets that could be assessed in future clinical trials. This NOFO uses a cooperative agreement mechanism (U01) and runs in parallel with a companion NOFO ( RFA-DK-28-214) .